A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection
Authors:
- Bogdan Ioan VintilaBVBogdan Ioan Vintila
- Anca Maria ArseniuAAAnca Maria Arseniu
- Claudiu MorgovanCMClaudiu Morgovan
- Anca ButucaAnca Butuca
- Victoria BîrluțiuVictoria Bîrluțiu
- Carmen Maximiliana DobreaCDCarmen Maximiliana Dobrea
- Luca Liviu RusLuca Liviu Rus
- Steliana GhibuSGSteliana Ghibu
- Alina Simona BereanuABAlina Simona Bereanu
- Rares ArseniuRARares Arseniu
- Ioana Roxana CodruICIoana Roxana Codru
- Mihai SavaMihai Sava
Open Access
- 1 February 2024
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 13 (2) , 144
Abstract
Clostridioides difficile is a Gram-positive bacteria that causes nosocomial infections, significantly impacting public health. In the present study, we aimed to describe the clinical characteristics, outcomes, and relationship between antibiotic exposure and Clostridioides difficile infection (CDI) in patients based on reports from two databases. Thus, we conducted a retrospective study of patients diagnosed with CDI from Sibiu County Clinical Emergency Hospital (SCCEH), Romania, followed by a descriptive analysis based on spontaneous reports submitted to the EudraVigilance (EV) database. From 1 January to 31 December 2022, we included 111 hospitalized patients with CDI from SCCEH. Moreover, 249 individual case safety reports (ICSRs) from EVs were analyzed. According to the data collected from SCCEH, CDI was most frequently reported in patients aged 65–85 years (66.7%) and in females (55%). In total, 71.2% of all patients showed positive medical progress. Most cases were reported in the internal medicine (n = 30, 27%), general surgery (n = 26, 23.4%), and infectious disease (n = 22, 19.8%) departments. Patients were most frequently exposed to ceftriaxone (CFT) and meropenem (MER). Also, in the EV database, most CDI-related ADRs were reported for CFT, PIP/TAZ (piperacillin/tazobactam), MER, and CPX (ciprofloxacin). Understanding the association between previous antibiotic exposure and the risk of CDI may help update antibiotic stewardship protocols and reduce the incidence of CDI by lowering exposure to high-risk antibiotics.Keywords
Funding Information
- Lucian Blaga University of Sibiu (LBUS-IRG-2022-08/No. 2878)
This publication has 66 references indexed in Scilit:
- Gender Bias in Autoimmunity Is Influenced by MicrobiotaImmunity, 2013
- Depression, antidepressant medications, and risk of Clostridium difficileinfectionBMC Medicine, 2013
- Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of AutoimmunityScience, 2013
- All-Cause and Disease-Specific Mortality in Hospitalized Patients With Clostridium difficile Infection: A Multicenter Cohort StudyClinical Infectious Diseases, 2013
- Higher Rates of Clostridium difficile Infection among SmokersPLOS ONE, 2012
- Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infectionJournal of Hospital Infection, 2012
- Time interval of increased risk for Clostridium difficile infection after exposure to antibioticsJournal of Antimicrobial Chemotherapy, 2011
- Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile InfectionClinical Infectious Diseases, 2011
- Antimicrobial‐Associated Risk Factors forClostridium difficileInfectionClinical Infectious Diseases, 2008
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987